Deirdre Flaherty is the VP of Development Project Strategy and Clinical Operations.  She works with the teams to drive the formation of strategy from candidate selection to clinical Proof of concept as well as leading the clinical implementation of the strategy. She has worked in the industry for over 25 years with roles in Clinical […]

Kimberly Long is Alchemab’s Vice President of Biology where she leads new target identification and validation. Prior to joining Alchemab Kimberly was Vice President of Biology at ROME Therapeutics and Casma Therapeutics. Prior to Casma Therapeutics, Kimberly held positions of increasing responsibility at Scholar Rock and Ironwood Pharmaceuticals. Kimberly eared a PhD in Biological Sciences […]

Becky is Alchemab’s Human Resources Director where she oversees all strategic and operational HR activity across the U.K. and U.S. Prior to Alchemab, Becky served as the European HR Director at Silence Therapeutics, where she managed all aspects of human resources for the U.K. and German entities. Prior to joining Silence Therapeutics, Becky held various […]

Jenny Howell oversees project management at Alchemab and is responsible for managing our research and development portfolio and projects. Prior to joining Alchemab, Jenny held strategic portfolio and project management roles at AstraZeneca, MedImmune, Alizyme Therapeutics and GSK.   Jenny earned a BSc in applied Chemistry from Northumbria University.

Martin Butler is our Vice President of Operations where he oversees Alchemab’s site and scientific operations, procurement, and supply chain functions. Prior to joining Alchemab, Martin was Global Supply Chain Director for Horizon Discovery where he managed operational activities at sites within the UK and USA and led the organization’s response to Brexit and the […]

Donna Finch is Alchemab’s Vice President of Translational and Clinical Science where she oversees our target discovery and validation activities and our non-clinical and early clinical development efforts. Prior to joining Alchemab, Donna was Associate Director, Respiratory Inflammation and Autoimmunity, R&D Biopharmaceuticals at MedImmune and AstraZeneca, leading pre-clinical biology, translational and early clinical activities of several […]